Greenman William Mariner

President and CEO at CERS; Director at CHINOOK THERAPEUTICS, INC.

Sold, on record
$6.5M
Dollars the filings state
Form 4 sales
17
Latest Jun 30, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale CHINOOK THERAPEUTICS, INC.No plan
    May 30, 2023 2023

    Sold 1,155 shares at $23.30 ($27k)

    Greenman William Mariner, Director

    No 10b5-1 planSold 4.7% of holdings ($578k position)23,643 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale CERSNo plan
    Mar 14, 2024 +289 days

    Sold 125,926 shares at $2.04 ($257k)

    Greenman William Mariner, President and CEO

    No 10b5-1 planSold 3.8% of holdings ($6.7M position)3.2M shares leftFiling

  3. 3 Form 4 sale CERSRoutine
    Mar 4, 2025 +355 days

    Sold 23,023 shares at $1.55 ($36k)

    Greenman William Mariner, President and CEO

    10b5-1 planSold 0.7% of holdings ($5M position)3.2M shares leftFiling

  4. 4 Form 4 sale CERSRoutine
    Mar 7, 2025 +3 days

    Sold 60,984 shares at $1.50 ($91k)

    Greenman William Mariner, President and CEO

    10b5-1 planSold 1.4% of holdings ($6.6M position)4.3M shares left1x usual sizeFiling

  5. 5 Form 4 sale CERSUnusual
    Mar 14, 2025 +7 days

    Sold 193,913 shares at $1.45 ($281k)

    Greenman William Mariner, President and CEO

    10b5-1 planSold 4.5% of holdings ($6.2M position)4.1M shares left3.2x usual sizeFiling

  6. 6 Form 4 sale CERSRoutine
    Mar 6, 2026 +357 days

    Sold 78,187 shares at $2.01 ($157k)

    Greenman William Mariner, President and CEO

    10b5-1 planSold 1.4% of holdings ($11.1M position)5.4M shares left0.8x usual sizeFiling

  7. 7 Form 4 sale CERSUnusual
    Mar 12, 2026 +6 days

    Sold 447,757 shares at $1.66 ($743k)

    Greenman William Mariner, President and CEO

    10b5-1 planSold 8.2% of holdings ($9M position)5M shares left5.7x usual sizeFiling

  8. 8 Form 4 sale CERSRoutine
    Jun 30, 2026 +110 days

    Sold 101,919 shares at $2.94 ($300k)

    Greenman William Mariner, President and CEO

    10b5-1 planSold 2% of holdings ($15.2M position)5.1M shares left1.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Greenman William Mariner
Source
Jun 30, 2026Jul 2, 2026CERSPresident and CEOForm 4 sale101,919$300k2.0%RoutineSEC
Mar 12, 2026Mar 16, 2026CERSPresident and CEOForm 4 sale447,757$743k8.2%UnusualSEC
Mar 6, 2026Mar 9, 2026CERSPresident and CEOForm 4 sale78,187$157k1.4%RoutineSEC
Mar 14, 2025Mar 17, 2025CERSPresident and CEOForm 4 sale193,913$281k4.5%UnusualSEC
Mar 7, 2025Mar 10, 2025CERSPresident and CEOForm 4 sale60,984$91k1.4%RoutineSEC
Mar 4, 2025Mar 5, 2025CERSPresident and CEOForm 4 sale23,023$36k0.7%RoutineSEC
Mar 14, 2024Mar 14, 2024CERSPresident and CEOForm 4 sale125,926$257k3.8%No planSEC
May 30, 2023May 31, 2023CHINOOK THERAPEUTICS, INC.DirectorForm 4 sale1,155$27k4.7%No planSEC
Mar 13, 2023Mar 14, 2023CERSPresident and CEOForm 4 sale60,480$169k2.2%Plan not statedSEC
Mar 14, 2022Mar 15, 2022CERSPresident and CEOForm 4 sale165,021$832k7.7%Plan not statedSEC
Feb 25, 2022Mar 1, 2022CERSPresident and CEOForm 4 sale308,263$1.8M16.2%Plan not statedSEC
Mar 15, 2021Mar 16, 2021CERSPresident and CEOForm 4 sale156,407$998k12.4%Plan not statedSEC
Mar 17, 2020Mar 24, 2020CERSPresident and CEOForm 4 sale108,011$388k11.6%Plan not statedSEC
Mar 13, 2019Mar 13, 2019CERSPresident and CEOForm 4 sale45,459$273k7.0%Plan not statedSEC
Mar 13, 2018Mar 13, 2018CERSPresident and CEOForm 4 sale17,766$88k4.8%Plan not statedSEC
Mar 15, 2017Mar 15, 2017CERSPresident and CEOForm 4 sale8,786$37k2.7%Plan not statedSEC
Nov 30, 2015Dec 2, 2015CHINOOK THERAPEUTICS, INC.DirectorForm 4 sale3,000$92k100.0%UnusualSEC